ArticleCureus2026
Occult Breast Cancer Presenting as Axillary Lymphadenopathy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occult breast cancer (OBC) is an intriguing entity posing great challenges in diagnosis and treatment. A 58-year-old female was referred to the breast department of our hospital with a metastatic left axillary node from breast carcinoma. Mammography, ultrasound, and MRI of the breast did not reveal any primary breast tumor. According to the decision of the multidisciplinary team, the patient underwent axillary lymph node dissection (ALND), followed by adjuvant chemotherapy, radiotherapy (RT), and hormone therapy. At present, three years later, the patient is free of disease. So far, various treatment options for OBC have been described. Although ALND combined with RT seems to be a safe oncological approach, limited evidence and individualized management in this radiologically occult disease are of paramount importance. Furthermore, awareness of this clinical entity is important for early diagnosis and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.